Bone News and Research RSS Feed - Bone News and Research

New osteoporosis drug may also be useful for treating brittle bone disease

New osteoporosis drug may also be useful for treating brittle bone disease

New research at the University of Michigan offers evidence that a drug being developed to treat osteoporosis may also be useful for treating osteogenesis imperfecta or brittle bone disease, a rare but potentially debilitating bone disorder that that is present from birth. [More]
New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

The physicians at Orthopaedic & Spine Center have put together an information guide – Surgery Isn't Always the Answer. The resource discusses conservative treatment options for those who suffer from hip, knee, and spine pain. The guide also shares information on the benefits of early diagnosis and minimally-invasive surgical treatments. [More]
Genetic markers may predict tumor samples that respond to treatment

Genetic markers may predict tumor samples that respond to treatment

Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer than half of patients. Now, a new study identifies a panel of genetic markers that predicted which tumor samples would likely respond to treatment. [More]
Ultrasound safer than other imaging modalities for imaging female pelvis, say OB/GYN experts

Ultrasound safer than other imaging modalities for imaging female pelvis, say OB/GYN experts

Ultrasound technology has evolved dramatically in recent years. A group of noted obstetricians and gynecologists maintain that ultrasound is more cost-effective and safer than other imaging modalities for imaging the female pelvis and should be the first imaging modality used for patients with pelvic symptoms. [More]
Study reveals link between dietary magnesium intake and diabetes-related health outcomes

Study reveals link between dietary magnesium intake and diabetes-related health outcomes

A recent analysis published in the Journal of Human Nutrition & Food Science reveals a beneficial relationship between dietary magnesium intake and diabetes-related outcomes including decreased risk for metabolic syndrome, obesity or overweight, elevated blood pressure, and reduced HDL (good) cholesterol. [More]
Higher levels of vitamin D decrease pain, improve function in obese patients with osteoarthritis

Higher levels of vitamin D decrease pain, improve function in obese patients with osteoarthritis

Got milk? If you are overweight and have osteoarthritis, you may want to bone up on your dairy products that have vitamin D. [More]
Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

The investigational S-equol nutritional supplement may be a viable agent to alleviate certain menopause symptoms, such as hot flashes, according to a new peer-reviewed article in the March Journal of Women's Health. [More]
Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy. [More]
Two surgical methods safe, effective for healing distal femur fractures

Two surgical methods safe, effective for healing distal femur fractures

A team of orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania has found that modern technology for healing distal femur fractures is as safe and effective as its more established alternative, without a potential shortfall of the older approach. [More]
FLS could reduce healthcare costs associated with osteoporotic fractures

FLS could reduce healthcare costs associated with osteoporotic fractures

Using a simulation model, Swedish researchers have shown that the implementation of Fracture Liaison Services (FLS) could considerably reduce the human and healthcare costs associated with osteoporotic fractures. The results from the model were presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Milan. [More]
Study demonstrates abnormal vitamin D levels in more than one-third of elite NCAA Division I athletes

Study demonstrates abnormal vitamin D levels in more than one-third of elite NCAA Division I athletes

A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk. [More]
New study estimates UK hospital costs of hip fracture

New study estimates UK hospital costs of hip fracture

A new study presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases reveals the high cost of first and subsequent hip fractures to the healthcare system in the UK. [More]
UAB scientist explores the bone development function of runx2 gene

UAB scientist explores the bone development function of runx2 gene

Amjad Javed, Ph.D., of the University of Alabama at Birmingham, has taken a major step forward in understanding the bone development function of a gene called runx2, which could lead to future ways to speed bone healing, aid bone bioengineering, stem osteoporosis and reduce arthritis. [More]
DFG Senate approves establishment of one Clinical Research Unit, five Research Units

DFG Senate approves establishment of one Clinical Research Unit, five Research Units

At its spring meeting in Bonn, the Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) approved the establishment of one new Clinical Research Unit and five new Research Units. [More]

Top experts focus on musculoskeletal disorders in open key Congress in Milan

Musculoskeletal conditions, which affect over 1.7 billion people worldwide, will be the focus of a major four-day Congress which opens today in Milan, Italy. [More]
Public volunteers to highlight their role in improving care for patients at Sheffield Consumers in Research event

Public volunteers to highlight their role in improving care for patients at Sheffield Consumers in Research event

RESEARCH-active members of the public are to showcase how their vital work helps shape clinical research projects and improves care for patients at a free drop-in event in Sheffield City Centre on Wednesday 22 April. [More]
Stopping cellular quality-control mechanism can make chemotherapy more effective

Stopping cellular quality-control mechanism can make chemotherapy more effective

A University of Rochester team found a way to make chemotherapy more effective, by stopping a cellular quality-control mechanism, according to a study published today in Nature Communications. [More]
Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced the launch and first commercial use of an updated SImmetry Sacroiliac Joint Fusion System. The surgery was performed by Dr. Brett Menmuir. [More]
apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

apceth begins Agenmestencel-T Phase II clinical trial in gastrointestinal cancer patients

apceth, a global leader in engineered cell therapies, today announced the successful completion of the Phase I and initiation of the Phase II part of its ongoing monocentric Phase I/II clinical trial TREAT-ME 1 with the engineered cell therapeutic product Agenmestencel-T, at the Klinikum Grosshadern in Munich. [More]

DePuy Synthes inks sales agreement with Radlink to offer real-time image guidance with hip replacement systems

DePuy Synthes Companies has signed an exclusive worldwide sales agreement with Radlink, Inc., an emerging global leader in advanced medical imaging technology, to offer real-time image guidance with its hip replacement systems. The agreement further demonstrates DePuy Synthes Companies’ ongoing commitment to help improve patient outcomes, increase patient satisfaction and reduce costs. [More]
Advertisement
Advertisement